Mecasermin (Human IGF-I; FK 780) is a recombinant human insulin-like growth factor I (IGF-I) . Mecasermin has the potential for the study of the growth failure of growth hormone (GH) insensitivity caused by GH receptor defects or GH-inhibiting antibodies[1].